Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs M Cash Integrasi Tbk. (MCAS) Price & Performance

UBC Medical Indonesia Tbk.Trade
M Cash Integrasi Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs M Cash Integrasi Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume), while M Cash Integrasi Tbk. trades at Rp318 (market cap 269.06B, 9.62M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2.4× M Cash Integrasi Tbk.'s market cap, and M Cash Integrasi Tbk. is more actively traded (9.62M versus 843K). Which is the better fit depends on your goals.

LABSMCAS
Market Cap
635.95B269.06B
Volume
843K9.62M
Lot
8.43K96.18K
Turnover
137.6M3.06B
Average Price
163.22318.11
Value
137.6M3.06B
Indicative Equilibrium Price
165318
Indicative Equilibrium Volume
2463.98K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
MCAS
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About M Cash Integrasi Tbk.

PT M Cash Integrasi Tbk (the Company) was established based on Notarial Deed No. 1 of UkonKrisnajaya, S.H., Sp.N. dated June 1, 2010.

Read more on MCAS